TEHR vs MyTelemedicine: Costs, Scope and Buyer Fit

How do TEHR and MyTelemedicine compare as of October 22, 2026?

This table separates vendor statements from unanswered questions. “Not stated on reviewed pages” means the public evidence did not establish an answer; it does not mean the capability is unavailable. Confirm the exact product, state coverage and service obligations in a written proposal.

Are you building a consumer brand or adding care to an existing organization?

The first decision is the job the platform must do. A health plan adding a virtual benefit, a diagnostic business needing clinical review and a founder selling a cash-pay subscription may all search for white-label telehealth. They do not have the same operating problem. The payer may need member eligibility and benefit reporting. The lab business may need authorized orders and reviewed results. The founder may need pricing, checkout, recurring payments and fulfillment coordination under a new brand.

MyTelemedicine’s technology page describes a configurable virtual-care platform, while its public audience pages address organizations such as labs and pharmacies. TEHR’s platform should be evaluated against the commercial and administrative workflow your brand needs. Start with one patient journey and the business outcome it supports. A broad feature list is useful only after you know whether the buyer is purchasing clinical access, practice software, consumer commerce or a coordinated combination of those services.

How much does the clinical model determine the technology decision?

Clinical access is not a single checkbox. Define the service, patient age range, encounter modality, clinical response expectations, follow-up process and states where demand already exists. Then identify the organization responsible for care. A nationwide description does not establish identical availability for every specialty or every patient situation. The required evidence is a program-specific coverage matrix and a clear process for routing a case that falls outside the offered service.

MyTelemedicine describes its clinician network and several care categories; TEHR provides infrastructure connected to independent licensed clinicians with 50-state reach, subject to program and eligibility constraints. Neither description should become a promise that any customer will receive a prescription. In the doctor-in-a-box guide, the important distinction is the separation between commercial ownership and clinical judgment. Ask both vendors who manages clinical quality, patient escalation and coverage changes, then ensure those responsibilities survive a platform transition.

What does a diagnostic or pharmacy partnership actually include?

A pharmacy can use telehealth to support patients while keeping its existing dispensing operation. That is different from a new brand outsourcing pharmacy sourcing, order routing, shipment tracking and exceptions. Similarly, a diagnostic company may want review of its own tests, whereas a new lab brand needs ordering, collection, processing, result delivery and appropriate clinical follow-up. The same word, integration, can conceal very different boundaries between the parties.

MyTelemedicine’s diagnostic-lab page describes approval and results-review workflows. Its retail-pharmacy page discusses branded care using existing infrastructure. These are credible reasons for those organizations to investigate the product, but they do not establish every fulfillment obligation in a DTC bundle. Ask TEHR to demonstrate the specific diagnostic workflow you require; do not assume a standalone lab-brand product. Use the lab-brand guide to list the actual operating stages, assign each one to an entity and identify which costs depend on specimen volume or prescription fulfillment.

How can you compare pricing when one side needs a scoped proposal?

Do not fill gaps in public pricing with a competitor’s estimate or an unattributed number from a sales conversation. Ask for a proposal based on the same service specification. Separate technology licensing, clinical services, implementation, integration maintenance, patient support, pharmacy charges and payment costs. Identify whether each line varies with members, completed encounters, orders, revenue or staff seats. A model that looks expensive for a small brand could be reasonable for a different population or service intensity.

TEHR uses a flat platform subscription plus flat transaction fee, with 0% revenue share; contact TEHR for a scoped quote. MyTelemedicine’s reviewed pages did not publish the equivalent commercial schedule. That means the comparison remains incomplete until a quote arrives, not that one side must be cheaper. Build a one-year operating case through TEHR pricing, then substitute the other proposal without changing the demand assumptions. Include integration support and the internal work needed to keep multiple organizations coordinated.

When should you choose TEHR?

Choose TEHR for evaluation when your central need is to operate a health brand with your own name, prices and customer experience while coordinating the clinical and fulfillment infrastructure behind it. Its operator background is relevant to questions about recurring billing, refill states, support ownership and migrating an existing consumer base. Ask for evidence around the exact moments that affect your business: incomplete intake after payment, a clinical decline, an order delay and a cancellation request.

This choice is conditional on the actual scope, not on a generic claim that a platform handles everything. Independent providers retain clinical authority. A branded experience still needs legally required identification of the entities delivering care. If you are moving established patients, use the migration checklist to inspect record quality and operational dependencies. TEHR’s stated experience migrating thousands of its own patients is not a guaranteed schedule for your organization.

When should you choose MyTelemedicine?

Choose MyTelemedicine for evaluation when the job begins with virtual clinical access inside an existing healthcare organization or established technology product. Its public material is particularly relevant to buyers with lab, pharmacy or health-plan infrastructure they intend to keep. Such buyers may care more about how a service connects to eligibility, clinical workflows and existing operations than about standing up a new consumer storefront.

Test the fit against your intended operating model rather than assuming enterprise breadth guarantees every specialized requirement. Ask whether your implementation uses the vendor’s patient workflow, your own workflow or both. Define how errors are observed and resolved across the boundary. Review the official platform description alongside MyTelemedicine alternatives if your shortlist includes products from different categories. A focused consultation service, an EHR and a turnkey brand platform can each be appropriate; the wrong comparison is the one that ignores what your team must still supply.

What should the implementation review contain?

Use a responsibility map with separate lanes for the brand, technology team, clinical entity, pharmacy or lab, payment provider and support team. For each patient event, name the system of record and the organization responsible for the next step. Include exceptions: an identity mismatch, a missing result, a patient in an unsupported program, a failed charge and a clinically urgent message. These situations reveal operational ownership more effectively than a happy-path demo.

Set acceptance criteria before implementation begins. They should cover data exchange, identity matching, access permissions, clinical handoffs, reconciliation and patient communications. Do not rely on a general promise of a smooth transition. Public transition language is not a detailed migration statement of work. Consult the white-label telehealth definition when aligning the parties, and use related resources for the adjacent business questions. Select the vendor whose documented scope meets the organization’s needs, then preserve the same responsibility map in the contract and launch checklist.

What else should you know?